The frequencies of Tim-3+ cells among CD8+ cells were significantly higher in CRC patients than those in normal volunteers (median, 6.78% vs 4.31%; p = 0.0232, Figure 1D). This evidence concerns the gene HAVCR2 and colorectal carcinoma.